BiotechTube

BIIB080 + BIIB080-matching placebo

Phase 2Active
0 watching 0 views this week⚡ Active
49
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Mild Cognitive Impairment Due to Alzheimer's Disease

Conditions

Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia

Trial Timeline

Aug 24, 2022 → Jan 8, 2029

NCT ID
NCT05399888

About BIIB080 + BIIB080-matching placebo

BIIB080 + BIIB080-matching placebo is a phase 2 stage product being developed by Biogen for Mild Cognitive Impairment Due to Alzheimer's Disease. The current trial status is active. This product is registered under clinical trial identifier NCT05399888. Target conditions include Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia.

Hype Score Breakdown

Clinical
17
Activity
12
Company
7
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT05399888Phase 2Active

Competing Products

20 competing products in Mild Cognitive Impairment Due to Alzheimer's Disease

See all competitors
ProductCompanyStageHype Score
Neurosteroid enantiomerOragenicsPhase 2
44
Ranirestat + PlaceboEisaiPhase 2/3
65
Aricept (donepezil hydrochloride) + placeboEisaiApproved
85
Donepezil HClEisaiApproved
85
Donanemab + AducanumabEli LillyPhase 3
77
PPAR alpha + Hydrochlorothiazide + PlaceboEli LillyPhase 2
52
ElagolixAbbVieApproved
85
AZD1446 + PlaceboAstraZenecaPhase 2
52
MEDI1814 for IV injection + MEDI1814 for Subcutaneous Injection + IV Placebo + Placebo for Subcutaneous InjectionAstraZenecaPhase 1
33
Fluticasone propionate (Flovent Diskus) 250 mcg + budesonide 400 mcgAstraZenecaApproved
85
AZD5213 + AZD5213 + AZD5213AstraZenecaPhase 2
52
budesonide/formoterol (Symbicort)AstraZenecaPhase 3
77
MK-8931MerckPhase 1
33
Montelukast to placebo + Placebo to montelukastMerckPre-clinical
23
Verubecestat 12 mg (Parts 1 and 2) + Verubecestat 40 mg (Parts 1 and 2)MerckPhase 3
77
Aliskiren + Hydrochlorothiazide + AmlodipineNovartisApproved
85
LCZ696 + SildenafilNovartisPhase 2
52
QCZ484 + PlaceboNovartisPhase 1
33
Rivastigmine PatchNovartisApproved
85
AFQ056NovartisPhase 1
33

Other Products from Biogen

Interferon-beta-1a + methylprednisoloneApproved
82
Dimethyl fumarateApproved
82
[18F]Florbetapir PET imagingApproved
82
dimethyl fumarateApproved
82
ibritumomab tiuxetan (Zevalin®)Approved
82